Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 18 Source: Estimated
- €514.4 million turnover
- 400 employees
-
31st Dec 17 Source: Estimated
- €321.6 million turnover
- 300 employees
- 4 more years available »
Ranking
By Turnover
(€514.4 million)- 152nd in Top Companies
- 22nd in Health
- 20th in Pharma
By Employees
(400)- 407th in Top Companies
- 64th in Health
- 41st in Pharma
- 400
- €514.4 million
Employees
- Shane Doyle Senior vice president
Latest News
- Aug 24 British Airways pilots to strike across three days in September
- Aug 24 Mastercard seeks bigger Dublin office amid rapid expansion
- Aug 24 Sunday Business Post owner in talks with publisher of Irish Tatler
- Aug 24 US investor has €2bn to spend on Irish construction
- Aug 23 Beacon Hospital posts €3.1m operating profit